The Food and Drug Administration, FDA, said Britain beat the US in authorizing the coronavirus vaccine because US regulators are more careful.
Peter Marks, director of the FDA's Center for Biological Evaluation, said the US regulator not only looks at the company's charts, but, "We get dirty and look at the actual adverse event reports."